Shop

0

Merck KGaA company report

£5,000.00
AstraZeneca report - standard
AstraZeneca company report -premium
In stock
Product Details

Detailed 40-60-page company report covering subjects of your choice. Ships within 2-3 weeks of purchase or of your chosen cut-off date.

Covers: company overview, strategy, growth drivers, newsflow, capital allocation and use of cash, guidance & transparency, management & incentive structures, key patent expirations, financials including 5-year forecast and flexible DCF-tool, key products, pipeline.

Soft copy delivery in Primavenue template of your choice and 60-90 minute discussion of findings with analyst Marietta Miemietz, CFA

Please send your cut-off date, template (if applicable) and/or any special requests (such as hard copies, or requests for binary pipeline modelling or coverage of additional drugs/projects for the premium report) to mm@primavenue.com

Save this product for later
Share this product with your friends
Merck KGaA company report
Share by: